Board of Directors

Our Board

Our Board of Directors provides the leadership and guidance necessary to execute our purpose.
Bruce C. Cozadd
Chairman and Chief Executive Officer, Jazz Pharmaceuticals plc
Paul L. Berns
Venture Partner, ARCH and Executive Chair, BlackThorn Therapeutics
Patrick G. Enright
Managing Director, Longitude Capital
Peter Gray
Chairman, Teckro, Inc. and Director, Abzena
Heather Ann McSharry
Director, CRH plc and Greencore plc
Seamus Mulligan
Director, Jazz Pharmaceuticals plc
Kenneth W. O’Keefe
Managing Director, Beecken Petty O’Keefe & Company
Anne O’Riordan
Group Director of Digital, Jardine Matheson
Norbert G. Riedel, Ph.D.
President and Chief Executive Officer, Aptinyx
Elmar Schnee
Chairman, Calliditas Therapeutics AB and Santhera Pharmaceuticals Holding AG
Catherine A. Sohn, Pharm.D.
Chairperson, BioEclipse Therapeutics Inc., and Director, Axcella Health Inc., Landec Corporation and Rubius Therapeutics
Rick E Winningham
Lead Independent Director, Jazz Pharmaceuticals plc; Chairman and Chief Executive Officer, Theravance Biopharma, Inc.

Our Board Committees

Our Board of Directors has three standing committees: an Audit Committee, a Compensation Committee and a Nominating & Corporate Governance Committee. The following table provides membership information for each committee.

 Audit CommitteeCompensation CommitteeNominating & Corporate Governance Committee
Paul L. Berns stroke-dot
Patrick G. Enright stroke-dotstroke-dot
Peter Gray solid-dot
Heather Ann McSharrystroke-dotsolid-dot
Kenneth W. O’Keefe stroke-dot
Anne O’Riordanstroke-dot
Norbert G. Riedelsolid-dot
Elmar Schnee stroke-dot
Catherine A. Sohnstroke-dotstroke-dot
Rick E Winningham*stroke-dot

solid-dot Committee Chairperson.
*Lead Independent Director.


Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
Corporate Governance Guidelines